ATYR PHARMA INC. overview

Thinking about buying stock in Eurocell, Maia Biotechnology, Figs, aTyr Pharma, or Bloom Energy? PR Newswire NEW YORK, Nov. 10, 2023 NEW YORK , Nov. 10, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ECEL, MAIA, FIGS, LIFE, and BE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ECEL:...

San Diego, California--(Newsfile Corp. - March 19, 2021) - aTyr Pharma, Inc. (NASDAQ: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview and participate in live Q&A at the Benzinga Biotech Small Cap Conference, which is being held March 24 - 25, 2021 in a virtual format. Company management...

...

...

...

aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors PR Newswire SAN DIEGO, April 3, 2017 SAN DIEGO , April 3, 2017 /PRNewswire/ -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the appointment of Mr. Jeffrey S. Hatfield , as an independent board director, to aTyr Pharma's board of directors, effective immediately. Mr. Hatfield...